Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study

Table 2 Paired post-pre changes (as a percent of the baseline) in HbA1c, blood glucose and lipids, blood pressure and body weight among patients in the intervention and control groups

	Mean ± SD of difference of relative changes related to start of the study		Lower confidence	Upper confidence	Paired t-test	df	P-value*
Intervention
HbA1c	−27.08 ± 12.90		−25.26	−28.90	−29.31	194	<0.001*
FBG	−17.10 ± 43.38		−10.91	−23.29	−5.45	190	<0.001*
Cholesterol	−9.93 ± 19.05		−7.19	−12.66	−7.16	188	<0.001*
Triglycerides	−3.84 ± 50.39		3.35	−11.03	−1.05	190	0.294
HDL	6.56 ± 51.96		13.98	−0.85	1.75	190	0.082
LDL	−11.44 ± 56.35		−3.46	−19.42	−2.83	193	0.005*
Systolic BP	−1.49 ± 10.36		−0.03	−2.95	−2.01	194	0.046*
Diastolic BP	−3.41 ± 12.34		−1.67	−5.15	−3.86	194	<0.001*
Body weight	3.72 ± 5.62		4.54	2.91	9.01	184	<0.001*
Control
HbA1c	18.75	122.04	48.29	−10.79	1.27	67	0.210
FBG	−0.74	49.16	11.16	−12.64	−0.12	67	0.901
Cholesterol	−4.10	11.28	−1.16	−7.04	−2.79	58	0.007*
Triglycerides	0.73	37.52	−9.82	8.35	0.16	67	0.873
HDL	−0.21	13.56	3.07	−3.49	−0.13	67	0.897
LDL	−1.65	41.20	8.33	−11.62	−0.33	67	0.743
Systolic BP	1.18	10.48	3.72	−1.35	0.93	67	0.356
Diastolic BP	−0.11	12.19	2.85	−3.06	−0.07	67	0.944
Body weight	0.16	4.44	1.24	−0.92	0.30	66	0.766

(*) Statistically significant at p < 0.05. The relative change was calculated as the mean change during the study divided by the mean at enrollment

ISSN: 2731-4553